• The ninth edition of the annual global event, ‘BioAsia-2012' to be held here in February next, is set to focus on vaccines, Intellectual Property Rights, Contract Research Organisation and Investments.

  • More business support elements like workshops, company presentations, luncheons and BioBazaar would be part of ‘BioAsia 2012'. For the first time, Sri Lanka would participate as a ‘partner country'.

  • In another new initiative, the organisers have decided to sponsor the visit of top regulator in the life-science field from SAARC countries like Nepal, Maldives and Bangladesh.

  • The global event will be held in Hyderabad.

  • The Genome Valley Excellence Awards 2012 will be given.

  • The Awards would be conferred on Dr. Seth Berkeley, CEO, GAVI Alliance, Geneva, for his extra-ordinary contributions to the vaccine sector and Merck & Co. for its ‘Patient & Health Vaccine Research' in addition to its support and backing to the initiatives focussed on cancers in women. Dr. Kevin Ali, president (emerging markets), Merck & Co., would receive the award on the company's behalf during Bio-asia 2012